Neutron radiation has better cure rate in prostate cancer patients. (Originated from Knight-Ridder Newspapers)Anstett, Patricia
tumor cells are killed by using X-rays. External beam therapy and internal radiation therapy are the two primary types of radiotherapy. Radiotherapy depends on various factors such as type of cancer, size of the tumor, location of the tumor in the body, and other general parameters of the bo...
For high-risk patients combination RT with or without androgen deprivation therapy seems to be superior. Furthermore, in a recently reported randomised trial (ASCENDE-RT, NCT00175396), a LDR boost was demonstrated to be much more effective than an EBRT boost in high-risk prostate cancer patients...
REAL-WORLD CLINICAL OUTCOMES OF MEDICARE PATIENTS WITH HIGH-RISK LOCALIZED PROSTATE CANCER TREATED WITH EXTERNAL BEAM RADIATION THERAPY OR RADICAL PROSTATE... Patients (pts) with high-risk localized prostate cancer (LPC) or locally advanced prostate cancer (LAPC) have several treatment options, ...
. Finally, in case of prostate cancer, radiotherapy with or without combined hormone therapy reveals comparable cure rates as surgical treatment efforts (Bolla et al.2002), albeit randomized trials are missing. Taken together, all these findings demonstrate the importance of radiotherapy as one of ...
"No other therapy besides salvage external beam radiotherapy has been shown to cure these patients," she adds. In 2009, an estimated 192,000 American men will have newly diagnosedprostate cancer. Approximately one-third (about 64,000 men) will choose radical prostatectomy as their primary treatmen...
Intra-operative radiation therapy is usually a component of a multi-disciplinary treatment approach for localized cancers that can not be completely removed or that have a high risk of recurring in nearby tissues. For patients with colorectal cancer, IORT has been associated with improved local ...
it is combined with radium-223 dichloride or avelumab in patients with metastatic prostate cancer non-responsive to hormonal therapy with or without immune therapy (NCT04071236), or is added on top of approved lutetium Lu-177 treatment for neuroendocrine tumors (NCT04750954). In summary, the eff...
Zelefsky MJ, Chan H, Hunt M, Yamada Y, Shippy AM, Amols H: Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 2006, 176: 1415-1419. 10.1016/j.juro.2006.06.002 Article PubMed Google Scholar van Tol-Geerdink...
“We thought one of the factors involved may be the sensitivity of the imaging tests used for planning radiation therapy. We thought this new PET test, with its greater sensitivity for detecting prostate cancer, would translate into a better cure rate, as well. We believed th...